Document:

alks_Ex_10-17-1

			

					

						 

					

					

						 

				
	

					

						

					

					

						Exhibit 10.17.1

				

		

			 

		

		
			April 24, 2017
		

		
			 
		

		
			 
		

		
			 
		

		
			Dear Craig,
		

		
			 
		

		
			On behalf of Alkermes Inc., I am pleased to offer you the position of Senior Vice President, Clinical Development and Medical Affairs, Chief Medical Officer, reporting to Elliot Ehrich,  Executive Vice President, Research and Development. This is a full-time exempt position and will be located in Waltham, MA.
		

		
			 
		

		
			This letter, and its accompanying documents, confirms the terms of the offer.
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Base Pay:

					
					
						Your starting annual salary will be $550,000, subject to applicable taxes and withholdings. You will be paid bi-weekly. 

				
	
					
						Annual Bonus:

					
					
						You will be eligible to participate in the 2017 Performance Pay Plan. Your annual Performance Pay target will be 50% and will not be prorated. Your actual Performance Pay will be based on individual and company performance. You must be actively employed by Alkermes on the date the bonus is paid to receive a Performance Pay bonus.

				
	
					
						Sign-On Bonus:

					
					
						You will receive a sign-on bonus of $250,000. This is a one-time payment that is considered wages and is therefore subject to supplemental income tax rates. Your sign-on bonus should be paid within thirty (30) days of your start date.

					
						If you voluntarily separate your employment with Alkermes prior to the first anniversary of your start date, you will be expected to return to Alkermes a prorated amount of your sign-on bonus. The prorated amount shall be calculated by multiplying 1/12th of your sign-on bonus amount ($250,000) by the total number of uncompleted months of service in the one year period from your start date.  Repayment of the prorated amount will be due to Alkermes within thirty (30) days of your last day of employment with Alkermes.

				
	
					
						Equity Participation:

					
					
						Subject to approval by the Compensation Committee of the Board of Directors of Alkermes plc, you will be granted the following equity grant;

					
						- A stock option grant of 80,000 stock options of Alkermes plc ordinary shares which will ratably vest over four (4) years on the anniversary of the grant date, provided that you remain employed by an Alkermes plc affiliated company.  The options shall expire on the earlier to occur of: the 10th anniversary of the date of grant or three months after termination of your service relationship with the Company.

					
						- A restricted stock unit award for 5,000 shares of Alkermes plc ordinary shares which will ratably vest over four (4) years on the anniversary of the grant date, provided that you remain employed by an Alkermes plc affiliated company.  In the event you cease to be employed by an Alkermes plc affiliated company, vesting shall cease.

				

		 

 

			

					

						 

					

					

						 

				
	

					

						 

					

					

						 

				

		

			 

		

	
					
						

					
						 

					
					
						In addition, Alkermes currently has a Performance Share Grant which all employees who begin working at Alkermes before December 31, 2017 are eligible for.  Subject to approval by the Compensation Committee of the Board of Directors of Alkermes plc, you will be granted a target grant of 8,000 Alkermes plc Performance Share Units that vest based on the company’s performance against stated milestones. The number of shares is based on your anticipated start date with Alkermes.  If your start date changes, the number of Performance Share Units may be adjusted. In the event you cease to be employed by an Alkermes plc affiliated company, vesting shall cease. Please see the attached information sheet for further information about this grant.  

					
						The above equity grants will be made from the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (the “Plan”) and will be subject to the terms and conditions of that Plan.  The Compensation Committee generally meets once per month to approve grants for employees who began employment at the company during the previous month.. The price of the stock option grant will be the closing price of the stock on the date of grant.  You will receive notice of your equity award grant via Alkermes/Merrill Lynch’s Benefits Online system.  Information regarding your equity grant including the grant award certificate(s) can also be found in the Alkermes/Merrill Lynch’s Benefits Online system and in the Plan.    We will provide you with a copy of the Plan for complete details.

				
	
					
						Vacation:

					
					
						In addition to location specific paid holidays, you are entitled to 3 weeks of annual vacation.  During this year, your vacation allotment will be prorated in accordance with Alkermes policy.

				
	
					
						Benefits:

					
					
						You will also be eligible to participate in the Alkermes benefits program as described in the accompanying Decision Guide. Medical, Dental, and Vision coverage will begin on your start date.  Complete details and enrollment information will be included with your New Employee Welcome Packet.

				
	
					
						Offer Contingencies:

					
					
						This employment offer is contingent upon successful completion of all aspects of the Alkermes pre-employment screening process. This process includes the verification of information you will provide to us for a background check.  

				
	
					
						Background

					
						Verification Process:

					
					
						This process will verify the information you have provided concerning your prior employment and education. As Alkermes is concerned with the security of our customers, employees, business partners and the general public, we will perform a criminal history check to determine whether you have criminal convictions of record and to verify your identity. For positions within our Finance department, a credit check will also be performed.

				
	
					
						Employment

					
						Eligibility 

					
						Verification:

					
					
						Please note that all persons in the United States are required to complete an Employment Eligibility Verification Form on the first day of employment and submit an original document or documents that establish identity and employment eligibility within three (3) business days of employment.  For your convenience, we are enclosing Form I-9 for your review.  You will need to complete Section 1 and present original document(s) of your choice as listed on the reverse side of the form once you begin work.

					
						Alkermes participates in the E-Verify program. E-Verify is a Social Security Administration/Department of Homeland Security program which allows employers to electronically verify each new employee’s work authorization using information provided on  Form I-9.   The verification process will occur within three (3) business days of employment.  If you would like further information regarding E-Verify, please contact Alkermes Human Resources department.

				

		 

 

			

					

						 

					

					

						 

				
	

					

						 

					

					

						 

				

		

			 

		

	
					
						

					
						Proprietary

					
						Information, 

					
						No Conflicts:

					
					
						You agree to execute the Company’s standard Employee Agreement With Respect to Inventions and Proprietary Information and Non-Solicitation and to be bound by all of the provisions thereof.  A copy is enclosed with this letter. You hereby represent that you are not presently bound by any employment agreement, confidential or proprietary information agreement or similar agreement with any current or previous employer that would impose any restriction on your acceptance of this offer or that would interfere with your ability to fulfill the responsibilities of your position with the Company.

				
	
					
						Employment Period:

					
					
						This letter, and its accompanying documents, set out the complete terms of our offer of employment but are not intended as, and should not be considered, a contract of employment for a fixed period of time. If you accept this offer of employment with the Company, you accept that your employment is at-will, which means that you or Alkermes are free to end the employment relationship at any time, with or without cause.

				

		
			 
		

		
			Craig, all of us here at Alkermes are very enthusiastic about the prospect of you joining the Company and have the highest expectation of your future contributions. 
		

		
			 
		

		
			Please indicate your acceptance of the foregoing with your signature, and return all completed documents to the Company no later than April 28, 2017.  After that date, the offer will lapse. The other duplicate original is for your records.
		

		
			 
		

		
			Best Regards,
		

		
			 
		

		
			
		

		
			 
		

		
			Madeline Coffin
		

		
			Senior Vice President, Human Resources
		

		
			Alkermes Inc.
		

		
			 
		

		
			The foregoing is signed and accepted as of the date first above written by:
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						/s/ Craig Hopkinson

					
					
						 

					
					
						25 April 2017

				
	
					
						Craig Hopkinson

					
					
						 

					
					
						DateExhibit

AMENDMENT NUMBER ONE
COLFAX CORPORATION 
DIRECTOR DEFERRED COMPENSATION PLAN
The Colfax Corporation Director Deferred Compensation Plan (the “Plan”) is hereby amended as follows, effective as of December 6, 2017:
		
	1.
	Section 3.2 is hereby deleted in its entirety and replaced with the following:

3.2       Form and Time of Payment

For each election that the Director completes and submits in connection with the Plan, which is confirmed by the Participant’s execution of a deferral agreement, the payment of his or her Deferred Stock Unit Account (or the portion thereof to which the election applies) is to be made in shares of Common Stock.

Pursuant to the Director’s election on the deferral agreement, the Director may irrevocably elect to receive payment of the Deferred Stock Unit Account (or the portion thereof to which the election applies) in the form of a lump sum payment or pursuant to an installment method to be paid annually over two (2) to ten (10) years.

If the Director elects on the deferral agreement to receive payment in a lump sum, payment of the Deferred Stock Unit Account (or the portion thereof to which the election applies) shall commence on the last day of the month after the Director’s termination of service, or as of January 31 of the 1st, 2nd, 3rd, 4th, 5th calendar year after termination of service in accordance with the particular election.

If the Director elects on the deferral agreement to receive payment pursuant to an installment method, payment of the Deferred Stock Unit Account (or the portion thereof to which the election applies) shall commence on January 31 of the 1st calendar year after termination of service and continue annually thereafter in accordance with the particular election, with the amount of each installment payment calculated by multiplying the balance of the Deferred Stock Unit Account (or the portion thereof to which the election applies) by a fraction, the numerator of which is one and the denominator of which is the remaining number of installment payments due to the Director.

Any fractional shares shall be distributed in cash.  
		
	2.
	Section 4.4 is hereby deleted in its entirety and replaced with the following:

4.4       Omnibus Incentive Plan

Shares of Common Stock delivered pursuant to this Plan shall be made from the Colfax Corporation 2016 Omnibus Incentive Plan or any successor plan (the “Omnibus Plan”) and shall be credited against the number of shares of Common Stock available for issuance under the Omnibus Plan.  

In all other respects the Plan, as amended herein, is hereby ratified and confirmed.
IN WITNESS WHEREOF, Colfax Corporation has caused this instrument to be signed by its duly authorized officer as of this  6th day of December, 2017.
COLFAX CORPORATION
By:  /s/ Lynn Clark
Its: SVP, Global Human Resources 

1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}]]